[HTML][HTML] lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment

H Jin, W Du, W Huang, J Yan, Q Tang, Y Chen… - … Therapy-Nucleic Acids, 2021 - cell.com
Breast cancer is a malignant tumor that has a high mortality rate and mostly occurs in
women. Although significant progress has been made in the implementation of personalized …

[HTML][HTML] The mechanisms of lncRNA-mediated multidrug resistance and the clinical application prospects of lncRNAs in breast cancer

P Ye, L Feng, S Shi, C Dong - Cancers, 2022 - mdpi.com
Simple Summary Multidrug resistance (MDR) is a major cause of breast cancer (BC)
chemotherapy failure. Long noncoding RNAs (lncRNAs) have been shown closely related to …

Long non-coding RNAs in drug resistance of breast cancer

T Du, Y Shi, S Xu, X Wan, H Sun, B Liu - OncoTargets and therapy, 2020 - Taylor & Francis
Breast cancer (BC) is the most common cancer and the leading cause of death in women.
Advances in early diagnosis and therapeutic strategies have decreased the mortality of BC …

[HTML][HTML] Emerging roles and potential applications of non-coding RNAs in glioblastoma

C DeOcesano-Pereira, RAC Machado… - International journal of …, 2020 - mdpi.com
Non-coding RNAs (ncRNAs) comprise a diversity of RNA species, which do not have the
potential to encode proteins. Non-coding RNAs include two classes of RNAs, namely: short …

Connexin 32 overexpression increases proliferation, reduces gap junctional intercellular communication, motility and epithelial-to-mesenchymal transition in Hs578T …

D Ugur, TB Gungul, S Yucel, E Ozcivici… - Journal of Cell …, 2022 - Springer
Connexins (Cx) are primary components of gap junctions that selectively allow molecules to
be exchanged between adjacent cells, regulating multiple cellular functions. Along with their …

[HTML][HTML] Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological …

L Záveský, E Jandáková, V Weinberger… - Cancer …, 2024 - content.iospress.com
BACKGROUND: Breast cancer is the most commonly occurring cancer worldwide and is the
main cause of death from cancer in women. Novel biomarkers are highly warranted for this …

[HTML][HTML] Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles

L Akhouayri, P Ostano, M Mello-Grand, I Gregnanin… - Human genomics, 2022 - Springer
Background Triple-negative breast cancer (TNBC) is a very heterogeneous disease. Several
gene expression and mutation profiling approaches were used to classify it, and all …

[HTML][HTML] Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL

D Bryant, L Smith, KR Rogers-Broadway, L Karydis… - Leukemia, 2023 - nature.com
Chronic lymphocytic leukaemia (CLL) cells can express unmutated (U-CLL) or mutated (M-
CLL) immunoglobulin heavy chain (IGHV) genes with differing clinical behaviours, variable …

Systematic survey of the regulatory networks of the long noncoding RNA BANCR in cervical cancer cells

B Wang, M Wang, S Jia, T Li, M Yang… - Journal of Proteome …, 2022 - ACS Publications
Long noncoding RNAs (lncRNAs) are increasingly recognized as functional regulators of
human cancers. BRAF-activated noncoding RNA (BANCR), an oncogenic lncRNA, has a …

RhoGDIβ inhibition via miR‐200c/AUF1/SOX2/miR‐137 axis contributed to lncRNA MEG3 downregulation‐mediated malignant transformation of human bronchial …

Y Yang, Z Tian, L He, H Meng, X Xie… - Molecular …, 2024 - Wiley Online Library
Nickel pollution is a recognized factor contributing to lung cancer. Understanding the
molecular mechanisms of its carcinogenic effects is crucial for lung cancer prevention and …